Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
21st Century
5%
African Ancestry
5%
Androgen Receptor
11%
Authorship Productivity
5%
Basic Fibroblast Growth Factor (bFGF)
9%
Bibliometric Data Sources
5%
Bilingual
5%
Bladder
6%
Bladder Cancer
23%
Cancer Cases
7%
Cancer Genome
9%
Cancer Predisposition
5%
Cell Interaction
5%
Contribution Index
5%
Convening
5%
Correction Patterns
5%
Culture Influence
5%
Developmental Deficits
5%
Developmental Effects
5%
Developmental Test
11%
Digital Libraries
5%
DNA Synthesis
5%
Emergent Literacy
5%
English Language Learners
7%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
11%
Equitable Transition
5%
European Ancestry
5%
Evolutionary Trajectory
7%
Funding Agencies
5%
Gender Considerations
5%
Gender Lens
5%
Gene Expression
6%
Gene Silencing
5%
Genome Analysis
95%
Genome-wide Association Study
8%
Hormone-sensitive Prostate Cancer
11%
Human Cancer
47%
Immunoreactivity
11%
In Cancer
17%
Infant Development
5%
Information Consistency
28%
Information Retrieval
5%
Iron Deficiency Anemia
8%
Iron Deficient
7%
Journal Acceptance Rate
5%
Letter to Editor
5%
LINE-1 Retrotransposition
11%
Long Non-coding RNA (LncRNA)
11%
Looking Back
5%
Mitochondrial DNA
17%
Modified Fractional Counting
7%
Molecular Characterization
17%
Moving Forward
5%
Multilevel Structural Equation Modeling
5%
Murine Double Minute 2 (MDM2)
11%
Mutant Huntingtin (mHTT)
5%
Nerve
7%
Nerve Regeneration
29%
Non-coding
7%
Non-endemic
8%
Open Research
5%
Oral Iron Therapy
11%
Pan-cancer Analysis
95%
Pathological Parameters
5%
Phonological Processing
5%
Phonological Skills
5%
Platform Research
5%
Preprints
5%
Prostate Cancer
53%
Prostate Cancer Risk
18%
Prostate-specific Antigen
6%
Publication Productivity
5%
Rapid Microwave
5%
Rat Leydig Cells
5%
Research Dissemination
5%
Research Environment
5%
Research Evolution
5%
Retrotransposition
5%
Scientific Databases
5%
Sertoli Cells
11%
Single nucleotide Polymorphism
8%
SNP
11%
SOLEIL Synchrotron
5%
Somatic Structural Variation
7%
Spanish Language
17%
Stage Progression
7%
Susceptibility Loci
7%
Synchrotron Facility
5%
Testicular Cell Culture
11%
Topical Evolution
5%
Tumor
12%
Type IV Collagen
5%
United Nations Sustainable Development Goals (UN SDGs)
5%
Urothelium
5%
Whole Genome
5%
Workbench
5%
X Chromosome Inactivation
5%
X-inactivation
8%
X-linked Genes
5%
Young Men
5%
Medicine and Dentistry
Androgen Receptor
5%
Biopsy Technique
6%
Bladder
15%
Bladder Cancer
24%
Bladder Neck
5%
Bone Metastasis
5%
Bone Morphogenetic Protein 6
5%
Brain Stem Response
5%
Cancer
57%
Cancer Classification
5%
Cancer Incidence
7%
Cancer Mortality
19%
Cancer Prognosis
5%
Cancer Staging
6%
Cancer Therapy
13%
Castration Resistant Prostate Cancer
5%
Cell Junction
5%
Central Nervous System
5%
Chromothripsis
5%
Clinician
5%
Cost-Effectiveness Analysis
5%
Cyclin D1
5%
Digital Rectal Examination
7%
Diseases
15%
Distractibility
5%
Division
5%
Ecological Study
5%
Epidermal Growth Factor Receptor
11%
Epithelium
5%
Exome
5%
External Beam Radiotherapy
5%
Fibroblast Growth Factor 8
11%
Fixative
5%
Gene Expression
5%
Genetic Marker
12%
Genetics
37%
Germ Cell
5%
Gleason Score
10%
Health Care Cost
17%
Heritability
5%
Human Genome
5%
Hypochromic Anemia
20%
Immunohistochemistry
6%
Immunoreactivity
8%
Incontinence
5%
Infancy
5%
Iron Deficiency
7%
Iron Supplement
7%
Irritability
5%
Kallikrein
5%
Laparoscopic Surgery
5%
Leydig Cell
5%
Long-Term Outcome
6%
Malignant Neoplasm
100%
Maturation
5%
Mendelian Randomization Analysis
5%
Messenger RNA
5%
Meta-Analysis
9%
Metastatic Carcinoma
9%
Microwave Irradiation
5%
Mitochondrial DNA
17%
Mitochondrial Genome
17%
Molecular Marker
12%
Mucin
5%
Neck Reconstruction
5%
Nerve Regeneration
5%
Neurogenesis
5%
Oncology
5%
Oral
5%
Overdiagnosis
7%
Pathogenesis
5%
Primary Biliary Cirrhosis
5%
Primary Tumor
6%
Prostate Biopsy
5%
Prostate Cancer
98%
Prostate Specific Antigen
44%
Prostatectomy
26%
Protein P53
8%
Quality of Life
5%
Radiation Therapy
5%
Randomized Clinical Trials
5%
Robot-Assisted Surgery
5%
Screening of Prostate Cancer
5%
Sertoli Cell
5%
Silent Mutation
5%
Somatics
15%
Surgeon
6%
Systematic Review
11%
Thalidomide
5%
Transitional Cell Carcinoma
7%
Tumor
33%
Urinary Tract
5%
Urothelium
5%
Ursodeoxycholic Acid
5%
Vasculotropin
5%
Biochemistry, Genetics and Molecular Biology
Acetylation
6%
Allele
8%
Androgen Receptor
16%
Artificial Neural Network
5%
Autosome
6%
Binding Protein
5%
BRIP1
5%
Cadherin
5%
Cancer Screening
5%
Cancer Staging
5%
Candidate Gene
5%
Carcinogenesis
10%
Case-Control Study
8%
Cell Function
7%
Chromatin Structure
5%
Chromosome
10%
Chromosome Structure
5%
Deficiency
5%
DNA Damage
5%
DNA Synthesis
5%
Dosage Compensation
5%
Epidermal Growth Factor Receptor
11%
Escherichia coli
5%
Exon
5%
Expression Level
5%
Extracellular Signal-Regulated Kinases
5%
Familial Aggregation
5%
Folic Acid
5%
Gene Expression
10%
Gene Inactivation
5%
Gene Linkage
6%
Gene Mutation
11%
Gene Polymorphism
5%
Genetic Association
5%
Genetic Correlation
9%
Genetic Divergence
8%
Genetic Marker
7%
Genetic Risk
5%
Genetic Transcription
5%
Genetics
21%
Genome Wide Association Study
8%
Genome-Wide Association Study
17%
Genomics
35%
Germline Mutation
5%
Glucose
5%
Haplotype
5%
HDAC1
5%
Histone Acetyltransferase
6%
Huntingtin
5%
Immunoreactivity
12%
Kallikrein
5%
Long Non-Coding RNA
11%
Long Noncoding RNA
5%
Mdm2
5%
Messenger RNA
7%
Microdissection
5%
Mitochondrial DNA
5%
Mitochondrial Genome
5%
Molecular Biology
7%
Molecular Phylogeny
5%
Mother Child Relation
5%
Negative Selection (Natural Selection)
7%
Nerve Regeneration
5%
Nuclear Hormone Receptor
6%
P53
15%
PALB2
5%
Pan-cancer
16%
Patient Coding
5%
Point Mutation
5%
Polygenic Score
7%
Prostate-Specific Antigen
11%
Protein Family
5%
Rat
5%
Real-Time Polymerase Chain Reaction
5%
Replication Timing
5%
Rett Syndrome
5%
RNA
7%
S100A4
5%
Single Nucleotide Polymorphism
20%
Single-Nucleotide Polymorphism
18%
Somatic Mutation
8%
Staining
7%
Susceptibility Gene
11%
Synapsin I
5%
Telomerase
5%
Transcription
9%
Transgene
6%
Tumor Suppressor Gene
5%
Ubiquitination
5%
UHRF1
5%
Vitamin D
5%
Whole Genome Sequencing
8%
X Chromosomal Inheritance
8%
X Chromosome
13%
X-Inactivation
36%